Skip to Content
주식/증권 📈 긍정적

Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth

요약

PRPO's first-quarter 2026 sales are driven by pathology momentum, but CMS reimbursement cuts and higher spending squeeze margins and widen losses.